Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Geron Corp (NASDAQ:GERN)

2.08
Delayed Data
As of 3:59pm ET
 -0.04 / -1.89%
Today’s Change
1.81
Today|||52-Week Range
5.29
-57.02%
Year-to-Date
4 Small-Cap Stocks Worth Buying in 2017
7:58am / MotleyFool.com - Paid Partner Content
3 Small-Cap Biotech Stocks That Could Double in 2017
Dec 02 / MotleyFool.com - Paid Partner Content

Today’s Trading

Previous close2.12
Today’s open2.10
Day’s range2.02 - 2.12
Volume1,350,168
Average volume (3 months)1,696,372
Market cap$337.4M
Dividend yield--
Data as of 3:59pm ET, 12/07/2016

Growth & Valuation

Earnings growth (last year)--
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)+3,054.47%
P/E ratioNM
Price/Sales21.65
Price/Book2.37

Competitors

 Today’s
change
Today’s
% change
BOLDAudentes Therapeutic...-0.48-3.11%
BTXBioTime Inc-0.09-2.73%
EDGEEdge Therapeutics In...+0.35+3.05%
ONVOOrganovo Holdings In...-0.07-2.22%
Data as of 4:00pm ET, 12/07/2016

Financials

Next reporting dateMarch 2, 2017
EPS forecast (this quarter)-$0.06
Annual revenue (last year)$36.4M
Annual profit (last year)$46.0K
Net profit margin0.13%

Profile

Sector
Health Technology
Industry
Biotechnology
President, Chief Executive Officer &
Director
John A. Scarlett
Chief Financial Officer, Treasurer &
Executive VP
Olivia K. Bloom
Corporate headquarters
Menlo Park, California

Forecasts


Search for Jobs